Viagra is the latest and cheapest anti-cancer drug
Viagra is the latest and cheapest anti-cancer drug
The medical site "MedicalXpress" highlighted the Viagra used in the treatment of erectile dysfunction, where a team of Belgian researchers found that they have a great ability to treat cancer.
Viagra, currently prescribed for men with erectile dysfunction, has been identified for inclusion in new anticancer drugs.
The discovery was from the ReDO, an international collaboration between the Belgian Cancer Fund.
With the cost of new cancer drugs rising, a major political issue faced by governments around the world, the task of the Cancer Fund is to identify which affordable drugs have the potential to save lives without high costs.
In the study, the researchers determined that selective phosphodiesterase 5 (PDE5) inhibitors have the ability to stop cancer. These inhibitors are a class of drugs that include Viagra, Tadalafil and Fardinafil more commonly known by their brand names Viagra, Cialis and Levitra.
"In many respects, sildenafil is the ultimate success story," said Dr. Pan Pantziarka of the Cancer Fund. "It was originally developed for angina, and was again prepared to treat erectile dysfunction, then again to pulmonary arterial hypertension , And now has the ability again as an anti-cancer drug.
PDE5 inhibitors show a wide range of mechanisms of action in different types of cancer, such as polymorphic adenoma, "brain tumors", a rare disease.